Management of Investigational Medicinal Products 
Clinical Trial Logistics
You are here : AccueilServices > Pharmaceutical Company Activity > Management of Investigational Medicinal Products (IMP)

Pharmaceutical Company Activity

Management of Investigational Medicinal Products (IMP)

Reception of IMP from manufacturer :
  • quarantine
  • verification
  • recording
Storage :
  • at ambient temperature, +4 to +8 °C, or - 20°C
  • Areas with controlled access and atmosphere
  • Dedicated areas identified for each project
  • 24 h /24 and 7days a week monitoring (telesurveillance)
Tracking of expiry dates
  • Alert programming
  • Informing client
Reception of request for sending (IVRS, fax, mail) and preparation of shipment
  • Treatment of request within the 24hrs or same day if urgent
  • Preparation of documents : request for shipment, analysis certificates, release certificates
Preparation and verification of shipments including 100% quality control
  • Packaging used adapted to each study in order to guarantee the integrity of products that are transported as well as minimising transport costs (weight/volume ratio)
  • Management of the cold chain : use of approved isothermic packaging
  • Recording of release
Distribution to investigation centres
  • Organisation of shipment (Express, courier service)
  • Tracking of the delivery
  • Management of acknowledgement receipts
  • Resupply to same sites if required and requested by client
Organisation of returns at study end :
  • Organisation of pick up from site
  • Verification at reception and recording
  • Reconciliation possible
  • Possibility of storage of returns in area with controlled atmosphere (if required)
Destruction of IMP or return to sponsor at study end :
Destruction certificate per project
Centralised randomisation (IVRS) in partnership with Cardinal Systems